Packing batteries with more punch
Indian researchers are working on cells that can store more energy, last longer
The Bench while expressing its serious concern, however, refrained from passing any blanket ban on the trials.
Taking a serious view of alleged use of human beings as guinea pigs for clinical trials by drug companies, the Supreme Court today asked the Centre and various states governments to reply to the allegation.
A Bench of justices R.M. Lodha and A.R. Dave also directed the Union Government to come out with details of the deaths, if any, and the side effects and compensation, if any, paid to the victims or their family members.
The apex court’s direction came during the hearing of a public interest litigation petition, filed by NGO Swasthya Adhikar Manch, alleging large scale clinical drug trials across the country by various pharmaceutical firms using Indian citizens as guinea pigs in those tests.
“We can even issue a one-line direction that all these clinical trials which affect many people must stop forthwith.
It must suffice, we are very serious about it,” the apex court told Additional Solicitor General Siddharth Luthra.
The Bench while expressing its serious concern, however, refrained from passing any blanket ban on the trials and instead sought a comprehensive reply from the Centre on the four issues.
The issues included number of applications received by the Union Government for clinical trials between January 1, 2005 and June 30, 2012.
The Bench secondly wanted to know “the number of deaths, if any, suffered by subjects of clinical trials and if yes, the number and nature of deaths.”
Third, the Bench sought to know “the serious side effects, if any, suffered by subjects of clinical trial and if yes, the number of such side effects and nature of side effects.”
The Bench also asked if any compensation was paid to the subjects who suffered side effects or to the family of subjects who died.
Indian researchers are working on cells that can store more energy, last longer
To fix a broken bone, doctors often harvest another bone from the patient’s body or from someone else. It ...
Superconductors from IIScScientists at IISc Bangalore have invented a device with a nanocrystal structure ...
Engineering and construction giant L&T has won a licence from the Council of Scientific & Industrial ...
Will a stock continue its current trend or will it reverse? We tell you how you can read chart patterns to ...
Option price falls more than it rises for the same change in underlying
A long-term vacation here is worth a check-in
The fund delivered a return of 31.5% in 2020 compared with the category’s 15.5%
In these isolated times when people yearn for a slice of the familiar, amateur and professional chefs are ...
With strokes of quirky humour, Partha Pratim Deb uses pulp, terracotta, glass and discarded cloth to create ...
Given the events in Washington DC on January 6, this week’s quiz is all about buildings that house or housed ...
While good writing wars against the cliché, television gives it a natural home
Digital is becoming dominant media, but are companies and their ad agencies transforming fast enough to make a ...
Slow Network, promoted by journalist-lyricist Neelesh Misra, pushes rural products and experiences
How marketers can use the traditional exchange of festive wishes meaningfully
For Fortune, a brand celebrating its 20th anniversary, it was a rude shock to become the butt of social media ...
Three years after its inception, compliance with GST procedures remains a headache for exporters, job workers ...
Corporate social responsibility (CSR) initiatives of companies are altering the prospects for wooden toys of ...
Aequs Aerospace to create space for large-scale manufacture of toys at Koppal
And it has every reason to smile. Covid-19 has triggered a consumer shift towards branded products as ...
Please Email the Editor